Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis
Reads0
Chats0
TLDR
Untreated maternal syphilis is associated with adverse pregnancy outcomes and these findings can inform policy decisions on resource allocation for the detection of syphilis and its timely treatment in pregnant women.Abstract:
OBJECTIVE: To perform a systematic review and meta-analysis of reported estimates of adverse pregnancy outcomes among untreated women with syphilis and women without syphilis. METHODS: PubMed, EMBASE and Cochrane Libraries were searched for literature assessing adverse pregnancy outcomes among untreated women with seroreactivity for Treponema pallidum infection and non-seroreactive women. Adverse pregnancy outcomes were fetal loss or stillbirth, neonatal death, prematurity or low birth weight, clinical evidence of syphilis and infant death. Random-effects meta-analyses were used to calculate pooled estimates of adverse pregnancy outcomes and, where appropriate, heterogeneity was explored in group-specific analyses. FINDINGS: Of the 3258 citations identified, only six, all case-control studies, were included in the analysis. Pooled estimates showed that among untreated pregnant women with syphilis, fetal loss and stillbirth were 21% more frequent, neonatal deaths were 9.3% more frequent and prematurity or low birth weight were 5.8% more frequent than among women without syphilis. Of the infants of mothers with untreated syphilis, 15% had clinical evidence of congenital syphilis. The single study that estimated infant death showed a 10% higher frequency among infants of mothers with syphilis. Substantial heterogeneity was found across studies in the estimates of all adverse outcomes for both women with syphilis (66.5% [95% confidence interval, CI: 58.0-74.1]; I(2) = 91.8%; P < 0.001) and women without syphilis (14.3% [95% CI: 11.8-17.2]; I(2) = 95.9%; P < 0.001). CONCLUSION: Untreated maternal syphilis is associated with adverse pregnancy outcomes. These findings can inform policy decisions on resource allocation for the detection of syphilis and its timely treatment in pregnant women.read more
Citations
More filters
Journal ArticleDOI
REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
Kevin Land,Debrah I. Boeras,Xiang-Sheng Chen,Xiang-Sheng Chen,Xiang-Sheng Chen,Andrew Ramsay,Rosanna W. Peeling +6 more
TL;DR: A Perspective discussing the factors that have contributed to the success and failure of point-of-care tests for resource-limited settings and the challenges and opportunities that exist for developing new infectious disease diagnostics.
Journal ArticleDOI
Global Estimates of Syphilis in Pregnancy and Associated Adverse Outcomes: Analysis of Multinational Antenatal Surveillance Data
Lori M. Newman,Mary L. Kamb,Sarah Hawkes,Gabriela B. Gomez,Gabriela B. Gomez,Lale Say,Armando Seuc,Nathalie Broutet +7 more
TL;DR: Using multinational surveillance data, Lori Newman and colleagues estimate global rates of active syphilis in pregnant women, adverse effects, and antenatal coverage and treatment needed to meet WHO goals.
Adding it up: The costs and benefits of investing in sexual and reproductive health 2014.
TL;DR: The sexual and reproductive health care that women need and use over the course of their lives is looked at and gaps in services that if filled could improve their health as well as that of their partners and children are identified.
Journal ArticleDOI
Global burden of maternal and congenital syphilis and associated adverse birth outcomes—Estimates for 2016 and progress since 2012
Eline L. Korenromp,Jane Rowley,Monica Alonso,Maeve B Mello,N. Saman Wijesooriya,S. Guy Mahiane,Naoko Ishikawa,Linh Vi Le,Morkor Newman-Owiredu,Nico J. D. Nagelkerke,Lori M. Newman,Mary L. Kamb,Nathalie Broutet,Melanie M. Taylor,Melanie M. Taylor +14 more
TL;DR: Achieving global CS elimination will require improving access to early syphilis screening and treatment in ANC, clinically monitoring all women diagnosed with syphilis and their infants, improving partner management, and reducing syphilis prevalence in the general population by expanding testing, treatment and partner referral beyond ANC.
Journal ArticleDOI
Treatment of Syphilis: A Systematic Review
TL;DR: Evidence defining treatment for HIV-infected persons and for pregnant women is limited, but available data support penicillin as first-line therapy, despite the relatively modest clinical trial data that support its use.
References
More filters
Journal ArticleDOI
Congenital Syphilis: A Description of 18 Cases and Re-examination of an Old but Ever-Present Disease
TL;DR: This upward trend in primary and secondary syph.
The global elimination of congenital syphilis: rationale and strategy for action.
TL;DR: It has been clearly shown that screening of pregnant women for reactive syphilis serology followed by treatment of seropositive women is a cost-effective inexpensive and feasible intervention for the prevention of congenital syphilis and improvement of child health.
Journal ArticleDOI
Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality
TL;DR: Detection and appropriate, timely penicillin treatment is a highly effective intervention to reduce adverse syphilis-related pregnancy outcomes and the GRADE recommendation is strong.
Journal ArticleDOI
Syphilis intervention in pregnancy: Zambian demonstration project.
Subhash K. Hira,Ganapati J. Bhat,D.M. Chikamata,Nkowane Bm,George Tembo,Peter L. Perine,A. Meheus +6 more
TL;DR: Although screening and treatment during intervention was suboptimal, the adverse outcomes attributable to syphilis were reduced to 28.3%; this is almost a two-third reduction when compared with 72.4% of adverse outcomes at control centres (p < less than 0.001).
Journal ArticleDOI
Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis.
TL;DR: Interventions to improve the coverage and effect of screening programmes for antenatal syphilis could reduce the syphilis-attributable incidence of stillbirth and perinatal death by 50% and be a worthwhile investment for reduction of adverse pregnancy outcomes and improvement of neonatal and child survival.